Betty Pace | Hematology | Best Researcher Award

Dr. Betty Pace | Hematology | Best Researcher Award

Dr. Betty Pace, Augusta University, United States

Dr. Betty Sue Pace, MD, is a Professor with tenure at Augusta University, serving in the Departments of Pediatrics and Biochemistry & Molecular Biology. ๐Ÿงฌ She holds the prestigious Francis J. Tedesco Distinguished Chair in Pediatric Hematology/Oncology and is a member of the Georgia Cancer Center. ๐ŸŒŸ With a medical degree from the Medical College of Wisconsin and postdoctoral training at the University of Washington, Dr. Pace is a leader in sickle cell disease research. โค๏ธ She has directed major research centers and served on national committees, including NIH and ASH. ๐Ÿ“š Her work promotes diversity, inclusion, and scientific advancement.

Publication Profile

Scopus

๐ŸŽ“ Education & Training

Dr. Betty Sue Pace began her academic journey at Lake Forest College in 1973, later earning her B.S. in Mathematics from Marquette University in 1976. โž— She pursued her M.D. in Medicine at the Medical College of Wisconsin, graduating in 1981. ๐Ÿฉบ Dr. Pace completed her Pediatric Internship and Residency (1981โ€“1984) at the same institutionโ€™s Childrenโ€™s Hospital. ๐Ÿ‘ถ She further specialized through a Pediatric Hematology/Oncology Fellowship at the University of Colorado Health Sciences Center (1987โ€“1990). ๐Ÿงฌ In 1990, she briefly served as a Locum Tenens Pediatrician before undertaking a Postdoctoral Research Fellowship at the University of Washington (1990โ€“1994).

๐Ÿ… Awards & Honors

Dr. Betty Sue Pace has received numerous prestigious accolades throughout her career. ๐ŸŒŸ In 1981, she was honored with the Kaiser Foundation Merit Award, Mosby Mirror Award, and Alpha Omega Alpha induction. ๐Ÿ† A Harold Amos Scholar in 1990, she was later named among Popular Scienceโ€™s โ€œBrilliant 10โ€ in 2003. ๐Ÿงช Her work earned her Lifetime Achievement (2007), Diversity Champion (2010), and Distinguished Researcher (2022) awards. ๐Ÿ’ผ She also established endowed scholarships in her name and currently serves as Editor-in-Chief of the Journal of Sickle Cell Disease (2025). ๐Ÿ“ฐ Her honors reflect a legacy of excellence in science, service, and inclusion.

Research Focus

Dr. Betty S. Paceโ€™s research is primarily centered on sickle cell disease (SCD), with a strong focus on oxidative stress, fetal hemoglobin induction, and gene regulation. ๐Ÿงฌ Her work explores epigenetic therapies, histone deacetylase inhibitors, and NRF2 activation to mitigate disease symptoms. ๐Ÿงซ She utilizes transgenic models, CRISPR techniques, and microRNA therapies to induce fetal hemoglobin expression and reduce ferroptosis. ๐Ÿ’‰ Her interdisciplinary research bridges molecular biology, hematology, and genomic innovation, aiming to develop novel therapeutic strategies for SCD. ๐Ÿง  Through collaborative studies and translational science, she is advancing curative solutions and improving patient outcomes worldwide.

Publication Top Notes

๐Ÿ“„ “Transsulfuration pathway activation attenuates oxidative stress and ferroptosis…” โ€“ Communications Biology, 2025 | Cited by: 1 ๐Ÿ“š๐Ÿงฌ

๐Ÿ“„ “CT-101 flips the switch to fetal hemoglobin expression…” โ€“ PLOS One, 2025 ๐Ÿงช๐Ÿงฌ

๐Ÿ“„ “Innovations in Drug Discovery for SCD Targeting Oxidative Stress and NRF2…” โ€“ Review, 2025 ย ๐Ÿ’Š๐Ÿง 

๐Ÿ“„ “Endothelial ENaC-a Restrains Oxidative Stress in Lung Capillaries…” โ€“ Am J Respir Cell Mol Biol, 2025 | Cited by: 2 ๐Ÿซ๐Ÿ”ฌ

๐Ÿ“„ “Hematopoietic cell transplant vs standard care in adolescents…” โ€“ Blood Advances, 2025 ย ๐Ÿงซ๐Ÿง’

๐Ÿ“„ “miR-29b induces fetal haemoglobin via promoter demethylation…” โ€“ Br J Haematol, 2025 ๐Ÿงฌ๐Ÿง 

๐Ÿ“„ “Correction to: CRISPR-mediated fetal chromatin domain ablations” โ€“ Scientific Reports, 2022 ย ๐Ÿงช๐Ÿ“˜

๐Ÿ“„ “Telehealth Use Among People with SCD During COVID-19…” โ€“ Telemedicine & e-Health, 2024 | Cited by: 1 ๐Ÿ’ป๐Ÿ“ž

๐Ÿ“„ “Simvastatin-Mediated Nrf2 Activation in SCD Mice…” โ€“ Antioxidants, 2024 | Cited by: 2 ๐Ÿงฌ๐Ÿ›ก๏ธ

๐Ÿ“„ “Emergency Department Visits by Individuals With SCD (1999โ€“2020)…” โ€“ Ajpm Focus, 2024 | Cited by: 6 ๐Ÿฅ๐Ÿ“ˆ

 

Romaric Tuono De Manfouo | Hematology | Best Research Article Award

Mr. Romaric Tuono De Manfouo | Hematology | Best Research Article Award

Mr. Romaric Tuono De Manfouo, Universitรฉ des Montagnes, Cameroon

Mr. Romaric Tuono De Manfouo is a dedicated Cameroonian biomedical researcher recognized for his contributions to hematology, infectious diseases, and public health. With a focus on sickle cell disease, hepatitis, and hematologic biomarkers, he has co-authored several peer-reviewed publications between 2019 and 2024. His research, often collaborative and cross-disciplinary, addresses critical health issues affecting vulnerable populations in Cameroon. Mr. Tuono De Manfouo has also served as a reviewer for reputable journals, showcasing his engagement with the broader scientific community. His scholarly output reflects a commitment to advancing diagnostic, therapeutic, and preventive approaches in low-resource settings. ๐Ÿงฌ๐ŸŒ๐Ÿ“š

Publication Profile

Orcid

๐ŸŽ“ Education

Mr. Romaric Tuono De Manfouo pursued his academic training in biomedical sciences at the Higher Institute of Health Sciences, Universitรฉ des Montagnes, Bangangtรฉ, West Cameroon. There, he specialized in clinical hematology, infectious diseases, and laboratory diagnostics, with an emphasis on tropical diseases and genetic disorders. His academic development was supported by rigorous coursework, clinical internships, and research mentorship. This foundation allowed him to explore the biochemical, immunologic, and epidemiological aspects of blood-related disorders, leading to impactful contributions in peer-reviewed journals. His academic background also includes training in research methodology and ethics, equipping him for multidisciplinary collaborations. ๐Ÿฅ๐Ÿ“–๐Ÿงช

๐Ÿ’ผ Experience

Mr. Tuono De Manfouo has contributed to both research and clinical diagnostics through academic affiliations with institutions in Cameroon. As a researcher, he co-authored multiple studies focused on sickle cell disease, hepatitis, and hematologic markers, published in international journals including the World Journal of Hematology and Biomedical Sciences. He has worked closely with clinicians, laboratorians, and public health experts on cross-sectional and serological studies. In addition, he served as a peer reviewer for journals such as Health Science Reports and Clinical Interventions in Aging. His collaborative roles underline his interdisciplinary expertise and scientific rigor. ๐Ÿ”ฌ๐Ÿง‘โ€โš•๏ธ๐Ÿ“

๐Ÿ… Awards and Honors

Although specific formal awards are not listed, Mr. Romaric Tuono De Manfouoโ€™s recognition comes through his scholarly activity and peer-review contributions. His invitation to review articles in well-regarded journals and his involvement in multiple high-impact studies signify his growing academic stature. His 2024 article in the World Journal of Hematology and his research on thrombotic risk in sickle cell patients stand out as significant achievements. His work continues to be acknowledged by academic peers and institutions for its relevance to public health in Sub-Saharan Africa. He is a promising candidate for research-based honors and awards. ๐Ÿ†๐Ÿ“„๐ŸŽ–๏ธ

๐Ÿ”ฌ Research Focus

Mr. Tuono De Manfouoโ€™s research centers on hematologic disorders, particularly sickle cell disease, iron metabolism, hemostasis, and infectious diseases like Hepatitis B. He investigates biomarkers such as haptoglobin, the genetic profile of G6PD deficiency, and the serological status of vulnerable populations. His studies aim to elucidate disease mechanisms, inform risk stratification, and enhance healthcare delivery in resource-limited settings. His preprints and published studies contribute to a better understanding of the inflammatory profile in pediatric patients and hematologic complications in chronic illnesses. His interdisciplinary approach bridges laboratory science, epidemiology, and clinical practice. ๐Ÿงซ๐Ÿงช๐Ÿฉธ๐Ÿง 

Publication Top Notes

๐Ÿ“Œ Plasminogen as a Marker for Assessing Thrombotic Risk During Hepatitis in Cameroon (2025) | Health Science Reports | DOI: 10.1002/hsr2.70648

๐Ÿ“Œ Haptoglobin Gene Polymorphism and Iron Profile in SCD Patients with Inflammation in Yaoundรฉ (2024) | Mol Genet Genomic Med | DOI: 10.1002/MGG3.2302

๐Ÿ“Œ Hematological and Hemostasis Profile, Thrombotic Risk in SCD in Cameroon (2024) | Hematology and Disorders | DOI: 10.58489/2836-3582/011 ๐Ÿฉบ

๐Ÿ“Œ Hyperuricemia and Associated Factors at Bafoussam Hospital (2024) | Health Science Reports | DOI: 10.1002/HSR2.1891

๐Ÿ“Œ Inflammation and Iron Profile in Children with SCD in Cameroon (2024) | Preprints.org | DOI: 10.20944/PREPRINTS202403.1721.V1 ๐Ÿฉธ

๐Ÿ“Œ Involvement of Haptoglobin in Disease Development (2024) | World Journal of Hematology | DOI: 10.5315/WJH.V11.I2.94171

๐Ÿ“Œ Prevalence of Anemia and Iron Deficiency Among Diabetics in West Cameroon (2024) | Preprint | DOI: 10.1101/2024.12.12.24318970 ๐Ÿฉธ

๐Ÿ“Œ Anti-Erythrocyte Alloimmunisation in RH System During CKD (2023) | Open Access Library Journal | DOI: 10.4236/OALIB.1109932

๐Ÿ“Œ G6PD Deficiency in Icteric Newborns in Yaoundรฉ (2023) | Open Journal of Blood Diseases | DOI: 10.4236/OJBD.2023.131005

๐Ÿ“Œ Homozygote Drepanocytosis: Ferric Status and Inflammation – Review & Meta-Analysis (2023) | Health Science Reports | DOI: 10.1002/HSR2.1609

๐Ÿ“Œ Serological Status of Hepatitis B Virus Among Pregnant Women (Mifi, Cameroon) (2023) | Biomedical Sciences | DOI: 10.11648/J.BS.20230902.12

๐Ÿ“Œ Serological Status of HBV Among Sex Workers in Douala (2023) | Biomedical Sciences | DOI: 10.11648/J.BS.20230902.13

๐Ÿ“Œ Assessment of Vulnerability to COVID-19 in Central Africa (2022) | Disaster Med Public Health Prep | DOI: 10.1017/DMP.2022.121